Troponin in COVID-19: To Measure or Not to Measure? Insights from a Prospective Cohort Study

Myocardial injury (MI), defined by troponin elevation, has been associated with increased mortality and adverse outcomes in patients with coronavirus disease 2019 (COVID-19), but the role of this biomarker as a risk predictor remains unclear. Data from adult patients hospitalized with COVID-19 were...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll-Bernardes, Renata, Mattos, João D., Schaustz, Eduardo B., Sousa, Andréa S., Ferreira, Juliana R., Tortelly, Mariana B., Pimentel, Adriana M. L., Figueiredo, Ana Cristina B. S., Noya-Rabelo, Marcia M., Sales, Allan R. K., Albuquerque, Denilson C., Rosado-de-Castro, Paulo H., Camargo, Gabriel C., Souza, Olga F., Bozza, Fernando A., Medei, Emiliano, Luiz, Ronir R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570932/
https://www.ncbi.nlm.nih.gov/pubmed/36233816
http://dx.doi.org/10.3390/jcm11195951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570932/
https://www.ncbi.nlm.nih.gov/pubmed/36233816
http://dx.doi.org/10.3390/jcm11195951

Ejemplares similares